Tuesday 17 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Earnings

Merck KGaA agrees to buy Rapid Micro Biosystems as maker pulls 2026 outlook

The US maker of rapid microbial testing instruments disclosed the takeover pact alongside quarterly sales of $9.5m, but gave no price, timetable or conditions.

16 Nov 2026 · Rapid Micro Biosystems, Inc. RPID · Company news

Rapid Micro Biosystems has signed a definitive agreement to be acquired by Merck KGaA of Darmstadt, Germany, the company said on 16 November 2026. The purchase is to be structured as a tender offer to shareholders, which had not been launched at the time of the announcement.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time

Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.

We'll email you a link to confirm your address, then take you to secure checkout (Stripe). Billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. Already a subscriber? Enter your email and the link will sign you in. See our terms and privacy policy.

Company's press release (SEC filing): Rapid Micro Biosystems, Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More EarningsAll →